- Motley Fool•18 hours ago
These drug kingpins are raking in the dough, which could lead to handsome returns for investors.
- Market Realist•20 hours ago
In 2016, Enbrel’s sales totaled ~$5.5 billion, which is a year-over-year rise of around 3.2%.
As questions arise about the execution of (or speed of execution) growth policies, some of the inflation optimism that has been priced in may begin to soften.
JNJ : Summary for Johnson & Johnson - Yahoo Finance
Johnson & Johnson (JNJ)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||118.05 - 118.90|
|52 Week Range||102.97 - 126.07|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||20.04|
|Dividend & Yield||3.20 (2.69%)|
|1y Target Est||N/A|